Dynamic changes of miRNA and cancer related proteins (CRPs) expression during neoadjuvant chemotherapy (NAC) for locally advanced breast cancer (LABC).

被引：0
|
作者：
Al-Khanbashi, Maria
Caramuta, Stefano
Al-Ajmi, Adel
Al-Hadabi, Ibrahim
Kumar, Shiyam
Dsouza, Philomena Charlotte
Zahld, Khawaja Farhan
Malik, Kamran Ahmed
Muhammad, Furrukh
Burney, Ikram A.
Al Bahrani, Bassim J.
Lui, Wang-onn
Al-Moundhri, Mansour S.
机构：
[1] Coll Med, Dept Med, Med Oncol Unit, Muscat, Oman
[2] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Oman
[3] Coll Med, Dept Surg, Mucat, Oman
[4] Coll Med, Dept Pathol, Muscat, Oman
[5] Coll Med, Dept Surg, Muscat, Oman
[6] Royal Hosp, Muscat, Oman
[7] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22099
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)?
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 121 - 121
  • [2] Gross and histologic features of locally advanced breast cancer (LABC) after neoadjuvant chemotherapy (NAC).
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 122 - 122
  • [3] Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).
    Puerto, VL
    Cardenas, J
    Lara, F
    Goana, R
    Silva, A
    Barroso, N
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 299 - 299
  • [4] Changes in Ki67 expression and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer (LABC)
    Devi, Desak Gede Agung Pramesti
    Purwanto, Heru
    Sandhika, Willy
    [J]. BALI MEDICAL JOURNAL, 2021, 10 (03) : 925 - 931
  • [5] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [6] Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment
    Al-Khanbashi, Manal
    Caramuta, Stefano
    Alajmi, Adil M.
    Al-Haddabi, Ibrahim
    Al-Riyami, Marwa
    Lui, Weng-Onn
    Al-Moundhri, Mansour S.
    [J]. PLOS ONE, 2016, 11 (04):
  • [7] NEOADJUVANT CHEMOTHERAPY (NAC) WITH DOCETAXEL AND LIPOSOME-ENCAPSULATED DOXORUBICIN IN LOCALLY ADVANCED HER2-BREAST CANCER (LABC)
    Merlano, M. C.
    Airoldi, M.
    Pedani, F.
    Contu, V.
    Margiotta, C.
    Fiore, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 102 - 102
  • [8] Inflammatory indicators as a prognostic factor of clinical response in locally advanced breast cancer (LABC) patients receiving neoadjuvant chemotherapy (NAC)
    Panigoro, Sonar Soni
    Patrianagara, Arga
    Sukartini, Ninik
    Pakasi, Trevino Aristarkus
    Haryono, Samuel Johny
    [J]. REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2024, 37 (01):
  • [9] Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).
    Abramova, Natalya A.
    Vladimirova, Liubov Yu
    Shikhliarova, Alla I.
    Storozhakova, Anna E.
    Kova, Valeriya S. Myag
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST-CANCER (LABC)
    SWAIN, S
    LIPPMAN, M
    BAGLEY, C
    SORACE, R
    WESLEY, M
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 55 - 55
12345